CASI Pharmaceuticals Dividends
| CASI Stock | USD 0.92 0.03 3.16% |
The CASI Pharmaceuticals' current Dividends Paid is estimated to increase to about (613.9 K). The current Dividend Yield is estimated to decrease to 0.01. CASI Pharmaceuticals' past performance could be the main factor of why investors trade CASI Pharmaceuticals stock today. Investors should clearly understand every aspect of the CASI Pharmaceuticals dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest CASI Pharmaceuticals' dividend schedule and payout information. CASI Pharmaceuticals dividends can also provide a clue to the current valuation of CASI Pharmaceuticals.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | -646.2 K | -613.9 K | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | (0.02) | (0.02) | |
| Dividend Paid And Capex Coverage Ratio | (35.08) | (36.84) |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in CASI Pharmaceuticals must own a stock before its ex-dividend date to receive its next dividend.
CASI Pharmaceuticals Dividends Paid Over Time
Today, most investors in CASI Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CASI Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of CASI Pharmaceuticals dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
CASI Pharmaceuticals Historical Dividend Yield Growth
A solid dividend growth pattern of CASI Pharmaceuticals could indicate future dividend growth is likely, which can signal long-term profitability for CASI Pharmaceuticals. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is CASI Pharmaceuticals dividend as a percentage of CASI Pharmaceuticals stock price. CASI Pharmaceuticals dividend yield is a measure of CASI Pharmaceuticals stock productivity, which can be interpreted as interest rate earned on an CASI Pharmaceuticals investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is there potential for Biotechnology market expansion? Will CASI introduce new products? Factors like these will boost the valuation of CASI Pharmaceuticals. Projected growth potential of CASI fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about CASI Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.02) | Revenue Per Share | Quarterly Revenue Growth (0.60) | Return On Assets | Return On Equity |
Investors evaluate CASI Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating CASI Pharmaceuticals' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause CASI Pharmaceuticals' market price to deviate significantly from intrinsic value.
It's important to distinguish between CASI Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CASI Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, CASI Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.